X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Insights

Cold Chain Technologies Supports the Boston Marathon® Jimmy Fund Walk Insulated packaging leader is the official sponsor of Refueling Station #6 in Wellesley, Massachusetts

Yuvraj_pawp by Yuvraj_pawp
8th September 2014
in Insights

Cold Chain Technologies (CCT), a market leading global manufacturer of insulated packaging solutions is proud to announce its participation in the Boston Marathon® Jimmy Fund Walk presented by Hyundai on September 21, 2014 as the official sponsor of Refueling Station #6 in Wellesley, Massachusetts. As sponsor of Refueling Station #6, employee volunteers of Cold Chain Technologies will distribute food and beverages to thousands of walkers en route to the Copley Square finish line. In addition to sponsoring the refueling station, CCT has organized Team Cold Chain, a group of walkers comprised of employees that have joined together to raise funds.

“We are honored to partake in such a special community event for a very worthy cause. Cancer is a disease that directly or indirectly affects us all. Not only are we proud to be a refueling station sponsor, but we’ve also organized a team of inspired employees that will participate in the Boston Marathon Jimmy Fund Walk to contribute additional support to Dana-Farber Cancer Institute and the Jimmy Fund,” said Larry Gordon, president of Cold Chain Technologies.

 

More than 8,500 participants are expected to participate in the Boston Marathon Jimmy Fund Walk, to honor friends, family, co-workers, and patients facing all forms of cancer. Walkers will complete one of the four routes: 26.2 miles starting from Hopkinton; 13.1 miles starting in Wellesley; 5 miles from Boston College; and 3 miles from Dana-Farber Cancer Institute’s campus, which includes many patients and their families. All routes end at the Copley Square finish line in Boston. Walkers begin in Hopkinton between 5:30 and 7:30 a.m. (rolling start); at Wellesley High School between 8:30 and 10:30 a.m. (rolling start); at Boston College between 10 a.m. and 12 p.m. (rolling start); and at Dana-Farber at 1:30 p.m.

 

The Boston Marathon Jimmy Fund Walk is the only event other than the Boston Marathon® itself that is sanctioned by the Boston Athletic Association to use the historic route. Since 1989, the Boston Marathon Jimmy Fund Walk has contributed nearly $95 million to support pediatric and adult cancer research and patient care at the Dana-Farber.

 

About The Jimmy Fund

 

The Jimmy Fund (www.JimmyFund.org) solely supports Boston’s Dana-Farber Cancer Institute, raising funds for adult and pediatric cancer care and research to improve the chances of survival for cancer patients around the world. It is an official charity of the Boston Red Sox, as well as the official charity of the Massachusetts Chiefs of Police Association, the Pan-Mass Challenge, and the Variety Children’s Charity of New England. Since 1948, the generosity of millions of people has helped the Jimmy Fund save countless lives and reduce the burden of cancer for patients and families worldwide. Follow the Jimmy Fund on Facebook: www.facebook.com/thejimmyfund and on Twitter: @TheJimmyFund.

 

About Dana-Farber Cancer Institute

 

Dana-Farber Cancer Institute, a principal teaching affiliate of Harvard Medical School, is world-renowned for its leadership in adult and pediatric cancer treatment and research. Designated as a comprehensive cancer center by the National Cancer Institute (NCI), it is one of the largest recipients among independent hospitals of NCI and National Institutes of Health grant funding. For more information, go to www.dana-farber.org.

 

About Cold Chain Technologies

 

Cold Chain Technologies (CCT) is a trusted worldwide provider of compliant thermal packaging solutions for the distribution and transport of temperature sensitive products. CCT’s full line of KoolTemp® insulated containers and Koolit® refrigerant products, and KoolTemp® GTS qualified shipping solutions are manufactured and distributed globally. Headquartered in Holliston, Massachusetts, Cold Chain Technologies is an ISO 9001:2008 registered company with over 45 years of ensuring product safety for the pharmaceutical, life science and food service industries.

 

SOURCE Cold Chain Technologies

Tags: Massachusetts
Previous Post

Sigma Pharmaceuticals buys Discount Drug Stores for $26.7m

Next Post

Par Pharmaceutical Resumes Shipment of Generic Precedex® Injection

Related Posts

Regulatory Trends in Pharma
Insights

Regulatory Trends in Pharma Manufacturing to Watch in 2025

29th May 2025
Pharmaceutical-Chemicals Market Booms with Rising API Demand
Asia

Pharmaceutical Chemicals Market Booms with Rising API Demand

28th May 2025
Insights

Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

27th May 2025
Capsules Market
Insights

Empty Capsules Market Growth to Reach $4.2B by 2029

16th April 2025
Omics Based Clinical Trials
Asia

Asia Pacific Omics-Based Clinical Trials Market Growth

16th April 2025
Insights

AstraZeneca Eyes Acquisition To Develop Cell Therapies

24th March 2025
Next Post

FDA Approves Use of Menactra® Vaccine for Booster Immunization Against Potentially Deadly Disease

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In